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Effects of n-3 fatty acids during neoplastic progression and comparison of
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Summary Several studies have shown that dietary lipid exerts an effect on carcinogenesis. We report here that
progression to malignancy in vitro is associated with changes in the response to fatty acids (FAs). Tumorigenic
(THKE) cells were more sensitive to the n-3 FAs eicosapentaenoic acid (EPA) and docosahexaenoic acid
(DHA) than immortalised (IHKE) cells. The growth of THKE cells was inhibited 25% more than the growth
of IHKE cells at 801tM EPA (P<0.01) and 35% more at 40ytM DHA (P<0.001). Furthermore, the results
indicate that there is a wide cell type variation in the response to FAs. We found that the in vitro inhibition by
FAs correlated with the reduction in the growth rate ofthe tumour in nude mice fed K85 (55% EPA and 30%
DHA). A significant difference in tumour latency was observed for the A427 cell tumour groups (10 days,
P< 0.05). Tumours in the animals fed n-3 FA exhibited significantly higher levels of EPA and DHA; the level
of arachidonic acid (ARA) was significantly lower in THKE tumours and the level of linoleic acid (LA) was
significantly lower in A427 tumours than in controls fed corn oil. The higher sensitivity of the A427 cell line
was not explained by higher uptake of EPA/DHA.
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Epidemiological studies suggest that dietary fat may be
involved in the aetiology of certain cancers (Armstrong and
Doll, 1975; Nicholson et al., 1988). In animal studies, the
level ofdietary fat intake influences chemically induced mam-
mary tumour initiation/promotion and the metastatic be-
haviour of the tumour. Some studies have shown that diets
rich in n-6 polyunsaturated fatty acids (PUFAs) (e.g. corn
oil, sunflower seed oil) stimulate tumour growth and develop-
ment (Hillyard and Abraham, 1979; Cave, 1991; Reddy et
al., 1991). In contrast, the n-3 fatty acids (FAs) (e.g. fish oil),
mainly eicosapentaenoic acid (EPA) and docosahexaenoic
acid (DHA), frequently inhibit growth of carcinogen-induced
tumours (Cohen et al., 1986; Minoura et al., 1988; Karmali
et al., 1989a; O'Connor et al., 1989; Takata et al., 1990;
Locniscar et al., 1991; Reddy et al., 1991; Cohen et al., 1993).
Diets rich in EPA and DHA inhibit the growth oftransplant-
able tumours in nude mice (Karmali et al., 1984, 1987;
Gabor and Abraham, 1986; Kort et al., 1987; Rose and
Cohen, 1988; Canizzo and Broitman, 1989; Sacaguchi et al.,
1990; Bravo et al., 1991). The inhibition of cell proliferation
when the growth medium is supplemented with n-3 FAs has
been well documented (Chow et al., 1989; Rose and Con-
nolly, 1991; H0stmark and Lystad, 1992), but the molecular
changes that n-3 FAs induce in the cells and variation in
sensitivity to n-3 FAs remain poorly understood.. Effects of
n-3 FAs are seen on the invasiveness of malignant murine
melanoma cells and human fibrosarcoma cells in cell culture
systems (Reich et al., 1989). A reduced ability to metastasise
experimentally has been shown in malignant murine mel-
anomas, colon carcinoma cells and mammary adenocar-
cinoma cell lines (Canizzo and Broitman, 1989; Reich et al.,
1989; Adams et al., 1990). Several cell lines resistant to
cytostatic drugs are sensitised by n-3 FA treatment in culture
(Burns and North, 1986; Zulstra et al., 1987; Timmer-
Bosscha et al., 1989; Burns et al., 1993; Krokan et al., 1993).
However, some resistant cell lines are not sensitised at all
(Krokan et al., 1993), and for some n-3-sensitive cell lines the
effect of combination of polyunsaturated fatty acids and
cytotoxic drugs is merely additive (Plumb et al., 1993).
Nevertheless, these results are very promising in relation to
treatment of human cancers. And in experimental models an
anticachectic effect occurs when a diet with n-3 triglycerides
is given to mice with certain tumours (Tisdale and Dhesi,
1990).
We have developed an in vitro human epithelial multistep
model suitable for the study of human epithelial car-
cinogenesis. This was developed following treatment with
Ni(II), leading to acquisition of a non-tumorigenic immortal
phenotype (Tveito et al., 1989). These immortalised human
kidney epithelial cells (IHKE) became tumorigenic after
transfection by Ha-ras (THKE cells) (Haugen et al., 1990).
Since various dietary FAs may influence tumorigenesis by
affecting the multistage process of carcinogenesis, we have
examined the possible effects of FAs in this model, and
whether in vitro tumour progression from normal to malig-
nancy is associated with changes in the response to FAs.
Materials and methods
Chemicals
RPMI-1640, alpha minimal essential medium (MEM),
Dulbecco's modified Eagle medium (DMEM), F12, EPA,
DHA ARA, insulin, hydrocortisone, epidermal growth factor
(EGF) and trypsin were obtained from Sigma (St Louis, MO,
USA). K85 was obtained from Pronova Biocare (Oslo, Nor-
way) and corn oil was purchased from Mills, Forma (Oslo,
Norway). Fetal calf serum (FCS) was obtained from Gibco
BRL.
Cell culture
Normal human kidney epithelial (NHKE) cells were cultured
in DMEM/F12 (1:1) medium supplemented with EGF
(10jig ml-'), insulin (5 jg ml '), hydrocortisone (36 ng mli 1),
transferrin (5 lgml-') and 5% fetal calf serum (FCS). IHKE
cell lines established from human kidney explants after treat-
ment with Ni(II) and the Ha-ras-transfected IHKE cells
(THKE) were cultured in DMEM/F12 supplemented with
1% FCS (Tveito et al., 1989; Haugen et al., 1990). During
the experiments 5% FCS was added to this medium. A427
human lung adenocarcinoma cells (from ATCC) were cul-
tured in RPMI-1640 medium supplemented with 10% FCS.
Normal human fibroblasts were grown in DMEM containing
10% FCS.
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Growth experiments
Cell growth was determined by seeding cells at an initial
density of 5 x 104 cells per 35 mm dish in triplicate for each
FA concentration. The next day the medium was changed
and different concentrations of free FA were added. On day
3 this was repeated, and on day 7 the cells were trypsinised
and counted. The FAs were stored at - 70°C as stock solu-
tions in ethanol under nitrogen. Diluted FAs were prepared
fresh and added to the cell culture medium. The concentra-
tion of ethanol never exceeded 0.6pl ml-1 in the medium. At
this level ethanol had no effect on cell proliferation or DNA
synthesis.
DNA synthesis was measured by seeding cells in 24well
culture dishes at a density of 2.5 x 104 cells per well. The
next day the medium was replaced with new medium sup-
plemented with the indicated concentrations of FAs. FAs
were added to the cell culture medium at 37°C in the different
concentrations 60 min before the medium was added to the
cell culture dishes. After 48 h the cells were labelled with
1.25 JACi of [3H]thymidine per well (specific activity 82.5 Ci
mmol '; New England Nuclear, Boston, MA, USA) for 4 h.
Cells were then fixed in ice-cold methanol for 10min, fol-
lowed by three washes in HEPES-buffered saline (HBS).
Unincorporated [3H]thymidine was extracted from the cells
by incubation in trichloroacetic acid (TCA) (5%, w/v) for
10 min at 4°C. The wells were then washed three times in
water and the cell monolayers were lysed in 0.5% sodium
dodecyl sulphate (SDS), 0.25 M sodium hydroxide at 60'C for
30min and radioactivity measured by liquid scintillation
counting.
Animalfeeding
The mice were fed a basal mixture supplemented with either
com oil (11% ofthe weight) or 6% or 8% K85 (a mixture of
n-3 ethyl esters of FAs). The total amount of fat was the
same in the experimental and the control groups (Table I).
Balb/cA (Bom) female athymic nude mice (5 weeks ofage)
were housed in filter top-cages in a pathogen-free laminar air
flow chamber at 26°C. The different diets were prepared,
immediately packed in plastic bags, flushed with nitrogen and
stored at -25°C. The mice were given the diet ad libitum
every day. Remaining food was removed the next morning.
The light/dark cycle was 12 h and relative humidity was
above 55% relative humidity.
After 2 weeks feeding on either n-3 FA ethyl esters K85 or
corn oil, 0.1 ml of HBS containing 5 x 106 cells was injected
s.c. All animals were monitored daily for tumour growth and
weighed weekly. Tumour volume was measured with calipers
using the formula: a x a x b/2 (where a is the shortest and b
is the longest measured diameter). The feeding experiments
were continued until some of the tumours reached a defined
limit of approximately 2 x 2 cm. The THKE tumour experi-
ment was terminated 90 days and the A427 tumour experi-
ment 99 days after cell inoculation. Tumours were removed
and processed for lipid analysis and histopathological evalua-
tion. Tissue sections were stained with haematoxylin and
eosin.
Table I Composition ofdiets in g 100g-'
K85 diet
Ingredients Corn oil diet THKE A427
Sunflower oil 1.0 1.0 1.0
Sucrose 58.0 58.0 58.0
Casein 20.0 20.0 20.0
Methionine 0.3 0.3 0.3
Mineral mixture 5.0 5.0 5.0
Vitamin mixture 0.7 0.7 0.7
Cellulose 4.0 4.0 4.0
Corn oil 11.0 3.0 5.0
K85 0 8.0 6.0
EthylesterK85contain 55% (ofallfattyacids)EPA,30% DHAanda
total of 95% n-3 fatty acids.
Fatty acid analysis
Extraction of total lipids, preparation of methylated fatty
acids and analysis by capillary gas chromatography was car-
ried out as described by Rainuzzo et al. (1992).
Statistical analysis
Differences in tumour volumes in the nude mice experiments
were tested using the Mann-Whitney test. Differences in
fatty acid composition and in cell growth were tested by
Student's t-test.
Results
In vitro growth response to ARA, EPA and DHA
The effects of various FAs on cell proliferation were studied
by determination of cell number and by incorporation of
radioactive thymidine.
NHKE, IHKE and THKE cells were incubated with
different concentrations of FAs. Figures 1 and 2 show the
effect of ARA, EPA, and DHA on cell proliferation and
DNA synthesis. The growth of NHKE cells was inhibited in
a concentration-dependent manner by the FAs. Logarith-
mically growing cells show 50% growth inhibition at 60, 40
and 35 I1M ARA, EPA and DHA, respectively, as measured
by increase in cell number. After a 4 h pulse of [3H]thymidine
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Figure 1 Effect of PUFA supplementation on cell proliferation
of human kidney epithelial cells (NHKE, IHKE and THKE).
Cells were grown for 7 days in different concentrations of ARA
(20:4, n-6) (U-*), EPA (20:5, n-3) (0-0) or DHA (22:6, n-3
(V-V). Error bars shown s.d.
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following treatment with FA for 48 h, the 50% inhibitory
dose was 55 and 65 tLM for EPA and DHA respectively.
IHKE and THKE cell growth was inhibited to some extent
by the three FAs, but the effect was less pronounced than in
NHKE cells. For IHKE cells the 50% inhibitory dose in cell
proliferation studies was 100 and 70iM FA for EPA and
DHA respectively, whereas for THKE cells the concentra-
tions were 80 and 60 gM.
The assay for thymidine uptake in the cells corresponds
well with the analysis ofcell proliferation except for the more
limited inhibitory effect of DHA on IHKE cells. This may be
due to difference in the duration of n-3 FA treatment in the
two assays (see Materials and methods).
Although NHKE cells show optimal growth at 5%, we
also performed experiments in which NHKE, IHKE and
THKE cells were grown in 1% FCS. Under these culture
conditions DNA synthesis studies showed a 50% inhibitory
dose at about 20 jLM for all three FAs. For IHKE cells the
50% inhibitory doses were 25, 30 and 60 gLM for DHA, ARA
and EPA respectively. For THKE cells 50% inhibitory doses
were 10, 50 and 70 gM for DHA, EPA and ARA respectively
(data not shown).
As shown in Figure 1, acquisition of the tumorigenic
phenotype increases the sensitivity of the cell line to n-3 FAs
compared with IHKE cells. The growth of THKE cells was
inhibited 25% more than the growth of IHKE cells at 80 giM
EPA (P<0.01) and 35% more at 40pM DHA (P<0.001).
For comparison, we then determined the 50% inhibitory
doses for a human tumour cell line that we had previously
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found is highly sensitive to n-3 FAs (A427) and for normal
human fibroblasts, which have been found to be resis-tant
(Krokan et al., 1993). The apparent 50% inhibitory dose for
A427 was between 5 and 10YM for all FAs (Figure 3). A
thymidine incorporation experiment gave similar results as
the cell proliferation study (data not shown). Fifty per cent
inhibition of the human fibroblast cell line was not obtained
within the concentration range tested (Figure 3).
In vivo experiments
None of the treatments used in the present study had any
effect on survival of the mice or on the tumour take rate in
any of the groups. Likewise, body weight data showed little
difference within the two groups (Figure 4). This is in agree-
ment with the lack of toxic effect observed in normal human
fibroblasts in vitro (Figure 3). However, a limited toxic effect
on some human cell types cannot be excluded.
The effect of K85 was tested on THKE and A427 cell
growth in vivo after implantation into the mice. For both cell
lines tested, tumour size at the end of the experiments was
smaller in K85-fed animals than in animals receiving a cont-
rol diet (Figures 5 and 6). The difference was significant for
the A427 tumours, but not significant for the THKE
tumours. By day 90 after cell inoculation, mean tumour
volume in the control mice approached 750mm3 (THKE)
and 800mm3 (A427), whereas tumours in the K85-treated
mice were 400mm3 (THKE) and 250mm3 (A427) respec-
tively. There was a significant difference in the tumour
latency in the experiment with A427 cells. The mean value
was 57 days and 67 days for the corn oil group and the K85
oil group respectively (P<0.05). No difference in tumour
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Figure 2 Effect of treatment with various concentrations of
ARA (A-U), EPA (0-*) or DHA (V-V) for 2 days on
[3H]thymidine uptake in NHKE, IHKE and THKE cell lines.
Error bars show s.d.
Figure 3 Effect of PUFA supplementation on cell proliferation
of a human lung adenocarcinoma cell line (A427). Cells were
grown for 7 days in different concentrations of ARA (20:4, n-6)
(U-U), EPA (20:5, n-3 (0-0) or DHA (22:6, n-3) (V-V).
The effect on the growth of a human fibroblast cell line after
treatment for 7 days with different concentrations of EPA (20:5,
n-3) (0-0) and DHA (22:6, n-3) (V-V) is shown. Error bars
show s.d.
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latency was observed for the THKE cells. Histological
examination showed morphology typical of kidney epithelial
tissue in the THKE tumours and of adenocarcinoma in the
A427 tumours.
FA measurements
The FA contents of the tumours are shown in Table II.
Tumours in the K85-fed animals have a significant higher
level of n-3 FAs (EPA and DHA). In addition, ARA was
significantly lowered after K85 in the THKE tumours,
whereas LA was significantly lowered in A427 tumours.
Table II shows a shift from <0.1 to 3.1 (EPA) and from 1.4
to 5.4 (DHA) in the THKE tumours and a shift from <0.1
to 2.6 (EPA) and from 0.3 to 4.5 (DHA) for A427 cells.
Discussion
Dietary lipids may be important determinants in car-
cinogenesis. Information from experiments on animal models
suggest that both the type and the amount of dietary lipids
can modulate tumour development and growth by acting
30
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during the initiation stage or-the promotion stage of car-
cinogenesis (Reddy and Maeura, 1984; Reddy et al., 1991).
One of the objectives of this study was to investigate
changes in cellular sensitivity to FAs during neoplastic pro-
gression in vitro. Immortalisation plays a critical role in
carcinogenesis. Studies indicate that both oncogenes and
tumour-suppressor genes are involved in the immortalisation
process (Shay et al., 1991). We have developed an in vitro
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Figure 5 Tumour volume of a transplantable human kidney
epithelial cell line (THKE) in nude mice. Balb/c female mice were
fed 1 week before cell inoculation with diet supplemented with
either K85 oil (0-0) or corn oil (0-0). Values at each point
are the mean of all tumour-bearing animals at that time. Error
bars show standard error of the mean (s.e.m.).
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Figure 4 Body weight of Balb/c female nude mice bearing
THKE tumours and A427 tumours throughout the feeding
experiments. 0-0, Diet rich in marine FAs; 0-0, diet rich
in vegetable FAs.
Days after cell inoculation
Figure 6 Tumour volume of a transplantable human lung
adenocarcinoma cell line (A427) in nude mice. Balb/c female
nude mice were fed 2 weeks before cell inoculation with a diet
supplemented with either K85 oil (0-0) or corn oil (0-0).
Values at each point are the mean of all tumour-bearing animals
at that time. Error bars show standard error of the mean (s.e.m.).
Table II Fatty acid composition of the tumours in per cent of all fatty acids, with s.e. of the mean in
parentheses
THKE A427
Fatty acid Controlgroup K85 group Controlgroup K85 group
16:0 palmitic acid 14.0 (1.0) 13.7 (0-3) 15.4 (0.4) 16.3 (1.3)
18:0 stearic acid 12.6 (0.8) 11.3 (0.8) 5.8 (1.4) 8.0 (0.7)
16:1, n-7 palmitoleic acid 2.4 (0.9) 3.4 (1.3) 11.5 (1.4) 12.2 (0.7)
18:1, n-9 oleic acid 9.8 (0-9) 10.9 (1.6) 28.4 (1.5) 25.7 (2.3)
18:2, n-6 linoleic acid 13.6 (1.0) 14.4 (1.4) 23.3 (3.2) 14.1 (0.9)
18:3, n-6 linolenic acid 0.2 (0.03) 0.2 (0.1) <0.1 <0.1
20:4, n-6 arachidonic acid 18.3 (1.2) 9.9 (2.1)** 5.6 (1.9) 3.8 (0.5)
20:4, n-3 eicosatetraenoic acid 0.8 (0.2) <0.1 <0.1 <0.1
20:5, n-3 eicosapentaenoic acid <0.1 3.1 (0.7)* <0.1 2.6 (0.3)***
22:5, n-3 docosapentaenoic acid <0.1 2.4 (0.6) <0.1 1.3 (0.2)
22:6, n-3 docosahexaenoic acid 1.4 (0.1) 5.4 (1.1)* 0.3 (0.1) 4.5 (0.3)***
*P<0.05; **P<0.01; ***P<0.001.
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model to study human epithelial cell transformation (Tveito
et al., 1989). Induction of immortalisation was achieved after
long-term exposure in vitro to Ni(II). v-Ha-ras integration in
the immortalised cell line resulted in tumorigenicity and has
facilitated studies ofchanges associated with tumour progres-
sion. The results obtained indicate that the tumorigenic
(THKE) cells were more sensitive to EPA/DHA at high
concentration level when added to culture medium than
Ni(II)-immortalised (IHKE) cells. Introduction of v-Ha-ras
into IHKE cells therefore resulted in increased sensitivity to
the growth-inhibitory effects of n-3 FAs. The increased cel-
lular sensitivity to n-3 FA might be affected by v-Ha-ras at
different levels, i.e. gene expression or modification of the
p21 ras protein by lipid moieties (Deschenes et al., 1990;
Distel et al., 1992). Our results therefore indicate that the
changed n-3 FA effect was a late event during the progres-
sion to malignancy. DNA sequence analysis of IHKE cells
has revealed a mutation in the p53 gene (Mvhle et al., 1992).
The mutated form of p53 may inhibit the antiproliferative
effect of FAs by interfering with its signalling pathway. Our
results are consistent with the effect of FAs in other systems,
but are in contrast to other in vitro studies in which n-3 FAs
were shown to be cytotoxic to tumorigenic cells while normal
cells were not killed (Begin et al., 1986; Das, 1991; Rose and
Connolly, 1991). However, the differences between NI4KE
cells and transformed cells may be a result of less than
optimal culture conditions for the NHKE cells. In addition,
NHKE cells have less growth potential than transformed
cells and may therefore be more easily perturbed after in vitro
treatments. We have found that reduced concentration of
FCS in the cell culture medium increases the toxicity of the
FAs to the kidney epithelial cells (data not shown). The
higher toxicity of FAs at lower FCS concentration may be
due to a protective effect of albumin (Lystad et al., 1994).
Previous studies have shown that there is a wide variation
in cellular sensitivity to FAs (Krokan et al., 1993). We found
A427 to be extremely sensitive to FAs, while IHKE and
THKE cells and human fibroblasts were more resistant to
FAs. The mechanism by which n-3 FAs affect cell prolifera-
tion is not yet clear. Gonzales (1990) proposed the hypothesis
that fish oils can inhibit mammary gland tumorigenesis by
increasing the level of peroxidation products. Previous
studies with IHKE cells have demonstrated that growth
inhibition in vitro by FAs increases with increasing number
of double bonds (Lystad et al., 1994), and there is a relation-
ship between the suppressive effect on cell proliferation and
thiobarbituric acid-reactive substances (TBARS) in the cul-
ture medium. It therefore seems that the production of lipid
peroxidation products may be an important cause of cell
toxicity in these cells. The agents responsible for this toxicity
may be highly toxic hydroxyalkenals (Esterbauer et al.,
1988). The cells' capacity to detoxify these aldehydes may be
an important determinant. However, other mechanisms by
which FAs may influence growth may be operating. A
significant reduction in the formation of growth-stimulatory
eicosanoids such as prostaglandin E2 and leukotrienes by n-3
FAs has been observed (Abou-El-Ela et al., 1989; Karmali et
al., 1989b). Recently, it was proposed that FAs can modulate
gene expression (Tiwari et al., 1991; Distel et al., 1992).
Previous studies have shown n-3 FAs to be effective
inhibitors of growth of a transplantable rat mammary car-
cinoma and of human breast and prostate cancer cells in
athymic nude mice fed fish oil rich in EPA and DHA (Rose
and Connolly, 1991; Welsch, 1992). In the present study the
in vitro inhibition by FAs is consistent with the in vivo
sensitivity when nude mice were fed K85 (55% EPA and
30% DHA). In the in vivo experiments DHA and EPA are
added to the diet as ethylesters, while corn oil added in the
control diet is in its natural triacylglycerol form. However,
the bioavailability of DHA and EPA as ethylesters and
triacylglycerol has been previously shown to be equal
(Krokan et al., 1993b). Therefore it is reasonable to compare
the effect of the two different chemical forms of FAs in the
same experiment. In the K85 fed animals both tumour types
incorporated large amounts of n-3 FAs, replacing in part n-6
FAs. The magnitude of the change in the n-3 composition of
the phospholipids of the resistant cell line did not seem to be
strikingly different from that in the sensitive cell line. How-
ever, in the nude mice fed corn oil we observed a significantly
lower incorporation of DHA in A427 tumours. Furthermore,
20:4, n-6 was reduced by some 50% in the THKE cells after
K85 treatment. If prostanoids derived from 20:4, n-6 are
important for the growth of this cell line, then the reduction
in 20:4, n-6 may explain this growth reduction. The present
study confirms that EPA and DHA reduce the level ofARA,
resulting in a decrease in the 2-series of prostaglandin syn-
thesis. The magnitude of incorporation of ARA in the A427
tumour fed corn oil was lower than in the THKE tumour.
This lower incorporation of ARA was in the A427 cell line
counterbalanced by LA. K85 did not change the incorpora-
tion of LA in the THKE tumour phospholipids.
It is concluded from these findings that acquisition of the
tumorigenic phenotype influenced the cellular sensitivity to
FAs. Further, the in vitro effect of FAs correlated with the
effect on tumour growth in nude mice. Further studies are
needed to understand the complexity of dietary lipid effects
during the stepwise progression to malignant cells. Relating
the diverse and cell-specific biological effects of FAs to
molecular mechanisms will help in understanding of the role
of dietary fat in human cancer.
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